Perth's Singular Health secures accelerated FDA clearance for its cloud-based 3DICOM MD Cloud, targeting US$16.5bn in healthcare inefficiencies. Read how this Australian innovation transforms medical imaging.
NeuroScientific Biopharmaceuticals shares surge after its StemSmart stem cell therapy shows significant clinical response in patients with fistulising Crohn's disease, validating its $5.1m acquisition.
Queensland researchers begin human trials for IB409, a revolutionary drug derived from funnel web spider venom that could prevent cell death during heart attacks and strokes.
Perth-based Singular Health Group submits 510(k) to US FDA for its cloud-based 3D medical imaging platform. Approval could transform global healthcare access and slash duplicate scan costs.
Former Woodside Energy boss Peter Coleman takes helm at PYC Therapeutics following board crisis and managing director's brief resignation. Key leadership change aims to restore investor confidence.
NeuroScientific Biopharmaceuticals has dosed a fourth patient with its StemSmart stem-cell therapy for fistulising Crohn's disease, marking a key step for the Australian biotech. Discover the potential of this game-changing treatment.
Two Western Australian researchers have claimed Australia's most prestigious science awards for developing revolutionary technology that could transform emergency medicine worldwide.
University of Wollongong researchers develop groundbreaking implant technology that could transform pancreatic cancer treatment in Australian healthcare.